sodium bisulfide has been researched along with Cardiomegaly in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Boer, RA; Frenay, AR; Hillebrands, JL; Leuvenink, HG; Pasch, A; Snijder, PM; van Goor, H | 1 |
| Hao, DD; Liu, J; Zhang, JS; Zhu, YC | 1 |
| Chen, Y; Huang, GY; Huang, SH; Moore, PK; Shi, YX; Yao, T; Zhu, YC; Zhu, YZ | 1 |
3 other study(ies) available for sodium bisulfide and Cardiomegaly
| Article | Year |
|---|---|
Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Models, Animal; Hydrogen Sulfide; Hypertension; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sulfides; Thiosulfates | 2015 |
Hydrogen sulphide inhibits cardiomyocyte hypertrophy by up-regulating miR-133a.
Topics: Animals; Cardiomegaly; Cell Line; Hydrogen Sulfide; Hypertrophy; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Reactive Oxygen Species; RNA, Messenger; Sulfides; Up-Regulation | 2011 |
Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Chemical Analysis; Blood Pressure; Cardiomegaly; Cardiotonic Agents; Collagen; Coronary Vessels; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrosis; Glyburide; Heart Rate; Heart Ventricles; Hydralazine; Hypertension; Male; Myocardium; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Sulfhydryl Compounds; Sulfides; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |